468 related articles for article (PubMed ID: 25118175)
1. Crystal structure of the RNA-guided immune surveillance Cascade complex in Escherichia coli.
Zhao H; Sheng G; Wang J; Wang M; Bunkoczi G; Gong W; Wei Z; Wang Y
Nature; 2014 Nov; 515(7525):147-50. PubMed ID: 25118175
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for promiscuous PAM recognition in type I-E Cascade from E. coli.
Hayes RP; Xiao Y; Ding F; van Erp PB; Rajashankar K; Bailey S; Wiedenheft B; Ke A
Nature; 2016 Feb; 530(7591):499-503. PubMed ID: 26863189
[TBL] [Abstract][Full Text] [Related]
3. Structural biology. Crystal structure of the CRISPR RNA-guided surveillance complex from Escherichia coli.
Jackson RN; Golden SM; van Erp PB; Carter J; Westra ER; Brouns SJ; van der Oost J; Terwilliger TC; Read RJ; Wiedenheft B
Science; 2014 Sep; 345(6203):1473-9. PubMed ID: 25103409
[TBL] [Abstract][Full Text] [Related]
4. Type III-A CRISPR-Cas Csm Complexes: Assembly, Periodic RNA Cleavage, DNase Activity Regulation, and Autoimmunity.
Jia N; Mo CY; Wang C; Eng ET; Marraffini LA; Patel DJ
Mol Cell; 2019 Jan; 73(2):264-277.e5. PubMed ID: 30503773
[TBL] [Abstract][Full Text] [Related]
5. The CRISPR RNA-guided surveillance complex in Escherichia coli accommodates extended RNA spacers.
Luo ML; Jackson RN; Denny SR; Tokmina-Lukaszewska M; Maksimchuk KR; Lin W; Bothner B; Wiedenheft B; Beisel CL
Nucleic Acids Res; 2016 Sep; 44(15):7385-94. PubMed ID: 27174938
[TBL] [Abstract][Full Text] [Related]
6. Structural Variation of Type I-F CRISPR RNA Guided DNA Surveillance.
Pausch P; Müller-Esparza H; Gleditzsch D; Altegoer F; Randau L; Bange G
Mol Cell; 2017 Aug; 67(4):622-632.e4. PubMed ID: 28781236
[TBL] [Abstract][Full Text] [Related]
7. Formation and Stoichiometry of CRISPR-Cascade Complexes with Varying Spacer Lengths Revealed by Native Mass Spectrometry.
Wittig S; Songailiene I; Schmidt C
J Am Soc Mass Spectrom; 2020 Mar; 31(3):538-546. PubMed ID: 32008319
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of the CRISPR-Cas RNA silencing Cmr complex bound to a target analog.
Osawa T; Inanaga H; Sato C; Numata T
Mol Cell; 2015 May; 58(3):418-30. PubMed ID: 25921071
[TBL] [Abstract][Full Text] [Related]
9. CRISPR RNA and anti-CRISPR protein binding to the
Hong S; Ka D; Yoon SJ; Suh N; Jeong M; Suh JY; Bae E
J Biol Chem; 2018 Feb; 293(8):2744-2754. PubMed ID: 29348170
[TBL] [Abstract][Full Text] [Related]
10. Modulating the Cascade architecture of a minimal Type I-F CRISPR-Cas system.
Gleditzsch D; Müller-Esparza H; Pausch P; Sharma K; Dwarakanath S; Urlaub H; Bange G; Randau L
Nucleic Acids Res; 2016 Jul; 44(12):5872-82. PubMed ID: 27216815
[TBL] [Abstract][Full Text] [Related]
11. Native tandem and ion mobility mass spectrometry highlight structural and modular similarities in clustered-regularly-interspaced shot-palindromic-repeats (CRISPR)-associated protein complexes from Escherichia coli and Pseudomonas aeruginosa.
van Duijn E; Barbu IM; Barendregt A; Jore MM; Wiedenheft B; Lundgren M; Westra ER; Brouns SJ; Doudna JA; van der Oost J; Heck AJ
Mol Cell Proteomics; 2012 Nov; 11(11):1430-41. PubMed ID: 22918228
[TBL] [Abstract][Full Text] [Related]
12. CRISPR RNA binding and DNA target recognition by purified Cascade complexes from Escherichia coli.
Beloglazova N; Kuznedelov K; Flick R; Datsenko KA; Brown G; Popovic A; Lemak S; Semenova E; Severinov K; Yakunin AF
Nucleic Acids Res; 2015 Jan; 43(1):530-43. PubMed ID: 25488810
[TBL] [Abstract][Full Text] [Related]
13. CasA mediates Cas3-catalyzed target degradation during CRISPR RNA-guided interference.
Hochstrasser ML; Taylor DW; Bhat P; Guegler CK; Sternberg SH; Nogales E; Doudna JA
Proc Natl Acad Sci U S A; 2014 May; 111(18):6618-23. PubMed ID: 24748111
[TBL] [Abstract][Full Text] [Related]
14. Structural biology. Crystal structure of a CRISPR RNA-guided surveillance complex bound to a ssDNA target.
Mulepati S; Héroux A; Bailey S
Science; 2014 Sep; 345(6203):1479-84. PubMed ID: 25123481
[TBL] [Abstract][Full Text] [Related]
15. The crystal structure of Cpf1 in complex with CRISPR RNA.
Dong D; Ren K; Qiu X; Zheng J; Guo M; Guan X; Liu H; Li N; Zhang B; Yang D; Ma C; Wang S; Wu D; Ma Y; Fan S; Wang J; Gao N; Huang Z
Nature; 2016 Apr; 532(7600):522-6. PubMed ID: 27096363
[TBL] [Abstract][Full Text] [Related]
16. Target RNA capture and cleavage by the Cmr type III-B CRISPR-Cas effector complex.
Hale CR; Cocozaki A; Li H; Terns RM; Terns MP
Genes Dev; 2014 Nov; 28(21):2432-43. PubMed ID: 25367038
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for assembly of non-canonical small subunits into type I-C Cascade.
O'Brien RE; Santos IC; Wrapp D; Bravo JPK; Schwartz EA; Brodbelt JS; Taylor DW
Nat Commun; 2020 Nov; 11(1):5931. PubMed ID: 33230133
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of the Cmr2-Cmr3 subcomplex in the CRISPR-Cas RNA silencing effector complex.
Osawa T; Inanaga H; Numata T
J Mol Biol; 2013 Oct; 425(20):3811-23. PubMed ID: 23583914
[TBL] [Abstract][Full Text] [Related]
19. Altered stoichiometry Escherichia coli Cascade complexes with shortened CRISPR RNA spacers are capable of interference and primed adaptation.
Kuznedelov K; Mekler V; Lemak S; Tokmina-Lukaszewska M; Datsenko KA; Jain I; Savitskaya E; Mallon J; Shmakov S; Bothner B; Bailey S; Yakunin AF; Severinov K; Semenova E
Nucleic Acids Res; 2016 Dec; 44(22):10849-10861. PubMed ID: 27738137
[TBL] [Abstract][Full Text] [Related]
20. Crystal Structures of Csm2 and Csm3 in the Type III-A CRISPR-Cas Effector Complex.
Takeshita D; Sato M; Inanaga H; Numata T
J Mol Biol; 2019 Feb; 431(4):748-763. PubMed ID: 30639408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
